Andreas Wagner Sells 21,118 Shares of Alignment Healthcare (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) insider Andreas Wagner sold 21,118 shares of Alignment Healthcare stock in a transaction that occurred on Wednesday, March 4th. The stock was sold at an average price of $18.62, for a total value of $393,217.16. Following the completion of the transaction, the insider owned 148,687 shares of the company’s stock, valued at approximately $2,768,551.94. The trade was a 12.44% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Alignment Healthcare Stock Performance

Shares of ALHC opened at $18.57 on Friday. The business’s fifty day moving average price is $20.96 and its 200 day moving average price is $18.63. Alignment Healthcare, Inc. has a 12-month low of $11.63 and a 12-month high of $23.87. The stock has a market capitalization of $3.79 billion, a PE ratio of -1,855.14, a price-to-earnings-growth ratio of 2.76 and a beta of 1.18. The company has a debt-to-equity ratio of 1.80, a current ratio of 1.71 and a quick ratio of 1.61.

Alignment Healthcare (NASDAQ:ALHC) last released its earnings results on Thursday, February 26th. The company reported ($0.05) earnings per share for the quarter, beating the consensus estimate of ($0.15) by $0.10. Alignment Healthcare had a negative net margin of 0.02% and a negative return on equity of 0.49%. The firm had revenue of $1.01 billion during the quarter, compared to analyst estimates of $1 billion. During the same quarter in the previous year, the firm earned ($0.16) earnings per share. The firm’s revenue for the quarter was up 44.4% compared to the same quarter last year. Equities research analysts forecast that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts have issued reports on ALHC shares. Robert W. Baird set a $28.00 target price on shares of Alignment Healthcare in a report on Friday, January 30th. KeyCorp reiterated an “overweight” rating and set a $28.00 price target on shares of Alignment Healthcare in a research report on Thursday, January 22nd. JPMorgan Chase & Co. raised their price target on Alignment Healthcare from $23.00 to $26.00 and gave the stock an “overweight” rating in a report on Thursday, February 5th. Wall Street Zen upgraded Alignment Healthcare from a “hold” rating to a “buy” rating in a research report on Saturday, February 7th. Finally, Piper Sandler upped their price objective on Alignment Healthcare from $20.00 to $30.00 and gave the stock an “overweight” rating in a research note on Tuesday, January 6th. One investment analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $24.56.

Institutional Investors Weigh In On Alignment Healthcare

Hedge funds have recently made changes to their positions in the business. Summit Securities Group LLC bought a new position in Alignment Healthcare in the 4th quarter worth approximately $26,000. Parallel Advisors LLC boosted its position in Alignment Healthcare by 87.7% during the 4th quarter. Parallel Advisors LLC now owns 1,654 shares of the company’s stock worth $33,000 after acquiring an additional 773 shares during the period. Larson Financial Group LLC bought a new position in shares of Alignment Healthcare in the third quarter worth $33,000. First Horizon Corp bought a new position in shares of Alignment Healthcare in the fourth quarter worth $39,000. Finally, SBI Securities Co. Ltd. increased its holdings in shares of Alignment Healthcare by 4,868.9% during the second quarter. SBI Securities Co. Ltd. now owns 3,031 shares of the company’s stock valued at $42,000 after purchasing an additional 2,970 shares during the period. Institutional investors own 86.19% of the company’s stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare’s approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.